EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 344 filers reported holding EXELIXIS INC in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $32,303,767 | +19.6% | 1,476,153 | +4.5% | 0.06% | +23.1% |
Q2 2023 | $27,004,510 | +57.3% | 1,413,109 | +59.8% | 0.05% | +52.9% |
Q1 2023 | $17,163,561 | +70.4% | 884,264 | +40.8% | 0.03% | +61.9% |
Q4 2022 | $10,074,857 | +1.8% | 628,108 | -0.5% | 0.02% | -4.5% |
Q3 2022 | $9,892,000 | +9.7% | 631,022 | +45.6% | 0.02% | +22.2% |
Q2 2022 | $9,019,000 | -3.0% | 433,448 | +5.6% | 0.02% | +12.5% |
Q1 2022 | $9,297,000 | -2.0% | 410,559 | -20.8% | 0.02% | +6.7% |
Q4 2021 | $9,488,000 | -5.0% | 518,658 | +9.6% | 0.02% | -11.8% |
Q3 2021 | $9,992,000 | +213.2% | 473,065 | +169.7% | 0.02% | +240.0% |
Q2 2021 | $3,190,000 | -65.0% | 175,428 | -56.6% | 0.01% | -68.8% |
Q1 2021 | $9,115,000 | +73.6% | 404,290 | +54.5% | 0.02% | +60.0% |
Q4 2020 | $5,252,000 | +5.8% | 261,624 | +28.8% | 0.01% | -9.1% |
Q3 2020 | $4,966,000 | -9.7% | 203,195 | -12.5% | 0.01% | -8.3% |
Q2 2020 | $5,498,000 | +131.3% | 232,131 | +68.5% | 0.01% | +100.0% |
Q1 2020 | $2,377,000 | +92.8% | 137,782 | +96.6% | 0.01% | +200.0% |
Q4 2019 | $1,233,000 | +31.2% | 70,066 | +31.7% | 0.00% | 0.0% |
Q3 2019 | $940,000 | -13.4% | 53,200 | +4.7% | 0.00% | 0.0% |
Q2 2019 | $1,085,000 | -40.8% | 50,791 | -34.1% | 0.00% | -33.3% |
Q1 2019 | $1,834,000 | -6.1% | 77,102 | -22.4% | 0.00% | -25.0% |
Q4 2018 | $1,953,000 | -53.1% | 99,330 | -57.8% | 0.00% | -50.0% |
Q3 2018 | $4,165,000 | +226.2% | 235,177 | +295.6% | 0.01% | +166.7% |
Q2 2018 | $1,277,000 | -59.3% | 59,445 | -58.1% | 0.00% | -40.0% |
Q1 2018 | $3,135,000 | -27.7% | 141,852 | +1.2% | 0.01% | -28.6% |
Q4 2017 | $4,335,000 | -35.0% | 140,212 | -49.0% | 0.01% | -36.4% |
Q3 2017 | $6,666,000 | +6.7% | 275,108 | +8.4% | 0.01% | 0.0% |
Q2 2017 | $6,250,000 | -53.8% | 253,796 | -59.4% | 0.01% | -56.0% |
Q1 2017 | $13,535,000 | +49.7% | 624,628 | +2.8% | 0.02% | +38.9% |
Q4 2016 | $9,040,000 | – | 607,558 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |